{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:19:49Z","timestamp":1792783189214,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Dean Research Funding of Nanfang Hospital, Southern Medical University, China","award":["2022A028"],"award-info":[{"award-number":["2022A028"]}],"id":[{"id":"https:\/\/ror.org\/01vjw4z39","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Malignant mesothelioma, a rare and aggressive cancer primarily caused by occupational asbestos exposure, has a poor prognosis. This study leverages the Global Burden of Disease (GBD) 2019 dataset to analyze the burden of mesothelioma linked to occupational asbestos exposure from 1990 to 2019. The analysis includes the number of mesothelioma deaths and disability-adjusted life years (DALYs) attributable to occupational asbestos exposure, focusing on trends in age-standardized mortality rate (ASMR) and age-standardized disability-adjusted life-year rate (ASDR) by year, age, sex, country, region, and Socio-demographic Index (SDI). In 2019, 91.7% of mesothelioma deaths and 85.2% of DALYs were attributable to occupational asbestos exposure, resulting in 26,820 (95% UI 24,312\u201328,622) deaths and 569,429 (95% UI 509,956\u2013617,484) DALYs. Despite a decline in ASMR and ASDR from 1990 to 2019, the absolute number of deaths and DALYs almost doubled. The United States reported the highest number of mesothelioma deaths, while China had the highest number of DALYs. Age-specific mortality rates and DALYs decreased in the 25\u201374 age group but increased in the 75+ age group. In conclusion, occupational asbestos exposure remains the primary cause of mesothelioma worldwide, with an increasing number of deaths and DALYs. The highest incidence rates are observed in high-income areas, and rates are rising in low-income areas. It is crucial to raise awareness about the hazards of asbestos to reduce the global burden of mesothelioma linked to occupational exposure.<\/jats:p>","DOI":"10.1007\/s00432-024-05802-6","type":"journal-article","created":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T14:53:35Z","timestamp":1717167215000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Global burden of mesothelioma attributable to occupational asbestos exposure in 204 countries and territories: 1990\u20132019"],"prefix":"10.1007","volume":"150","author":[{"given":"Zhiming","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yikuan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongyin","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huajie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhizhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaican","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,28]]},"reference":[{"issue":"6","key":"5802_CR1","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1111\/crj.12778","volume":"12","author":"O Abdel-Rahman","year":"2018","unstructured":"Abdel-Rahman O (2018) Global trends in mortality from malignant mesothelioma: analysis of WHO mortality database (1994\u20132013). Clin Respir J 12(6):2090\u20132100. https:\/\/doi.org\/10.1111\/crj.12778","journal-title":"Clin Respir J"},{"issue":"4","key":"5802_CR2","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1136\/oem.39.4.344","volume":"39","author":"ED Acheson","year":"1982","unstructured":"Acheson ED, Gardner MJ, Pippard EC et al (1982) Mortality of two groups of women who manufactured gas masks from chrysotile and crocidolite asbestos: a 40-year follow-up. Br J Ind Med 39(4):344\u2013348. https:\/\/doi.org\/10.1136\/oem.39.4.344","journal-title":"Br J Ind Med"},{"issue":"3","key":"5802_CR3","doi-asserted-by":"publisher","first-page":"531","DOI":"10.3390\/ijerph15030531","volume":"15","author":"LP Allen","year":"2018","unstructured":"Allen LP, Baez J, Stern MEC et al (2018) Trends and the economic effect of asbestos bans and decline in asbestos consumption and production worldwide. Int J Environ Res Public Health 15(3):531. https:\/\/doi.org\/10.3390\/ijerph15030531","journal-title":"Int J Environ Res Public Health"},{"issue":"Suppl 1","key":"5802_CR4","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.21037\/tlcr.2019.11.11","volume":"9","author":"N Alpert","year":"2020","unstructured":"Alpert N, van Gerwen M, Taioli E (2020) Epidemiology of mesothelioma in the 21(st) century in Europe and the United States, 40 years after restricted\/banned asbestos use. Transl Lung Cancer Res 9(Suppl 1):S28\u2013S38. https:\/\/doi.org\/10.21037\/tlcr.2019.11.11","journal-title":"Transl Lung Cancer Res"},{"issue":"5\u20136","key":"5802_CR5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1080\/10937404.2016.1193361","volume":"19","author":"P Andujar","year":"2016","unstructured":"Andujar P, Lacourt A, Brochard P et al (2016) Five years update on relationships between malignant pleural mesothelioma and exposure to asbestos and other elongated mineral particles. J Toxicol Environ Health B Crit Rev 19(5\u20136):151\u2013172. https:\/\/doi.org\/10.1080\/10937404.2016.1193361","journal-title":"J Toxicol Environ Health B Crit Rev"},{"key":"5802_CR54","unstructured":"Asbestos and Silica Safety and Eradications Agency. (2016). Asbestos is banned in Australia.  on the use of all types of asbestos took effect on 31\nDecember 2003. Work Health and Safety (WHS) and environment laws in all States and Territories prohibit the\nunauthorised supply, transport, use (including manufacturing), or handling of asbestos.Available from: https:\/\/www.asbestossafety.gov.au\/importing-and-exporting-asbestos\/asbestos-banned-australia. Accessed 21 Mar 2024"},{"issue":"159","key":"5802_CR6","doi-asserted-by":"publisher","first-page":"200226","DOI":"10.1183\/16000617.0226-2020","volume":"30","author":"R Asciak","year":"2021","unstructured":"Asciak R, George V, Rahman NM (2021) Update on biology and management of mesothelioma. Eur Respir Rev 30(159):200226. https:\/\/doi.org\/10.1183\/16000617.0226-2020","journal-title":"Eur Respir Rev"},{"issue":"7","key":"5802_CR7","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s00420-019-01433-4","volume":"92","author":"P Boffetta","year":"2019","unstructured":"Boffetta P, Donato F, Pira E et al (2019) Risk of mesothelioma after cessation of asbestos exposure: a systematic review and meta-regression. Int Arch Occup Environ Health 92(7):949\u2013957. https:\/\/doi.org\/10.1007\/s00420-019-01433-4","journal-title":"Int Arch Occup Environ Health"},{"issue":"12","key":"5802_CR8","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1136\/oem.2006.031724","volume":"64","author":"A Burdorf","year":"2007","unstructured":"Burdorf A, Jarvholm B, Siesling S (2007) Asbestos exposure and differences in occurrence of peritoneal mesothelioma between men and women across countries. Occup Environ Med 64(12):839\u2013842. https:\/\/doi.org\/10.1136\/oem.2006.031724","journal-title":"Occup Environ Med"},{"key":"5802_CR9","doi-asserted-by":"publisher","first-page":"1333661","DOI":"10.3389\/fimmu.2023.1333661","volume":"14","author":"L Calabro","year":"2023","unstructured":"Calabro L, Bronte G, Grosso F et al (2023) Immunotherapy of mesothelioma: the evolving change of a long-standing therapeutic dream. Front Immunol 14:1333661. https:\/\/doi.org\/10.3389\/fimmu.2023.1333661","journal-title":"Front Immunol"},{"key":"5802_CR10","doi-asserted-by":"publisher","first-page":"120507","DOI":"10.1016\/j.jenvman.2024.120507","volume":"355","author":"G Capitani","year":"2024","unstructured":"Capitani G, Dalpiaz M, Vergani F et al (2024) Recycling thermally deactivated asbestos cement in mortar: a possible route towards a rapid conclusion of the \u201casbestos problem.\u201d J Environ Manage 355:120507. https:\/\/doi.org\/10.1016\/j.jenvman.2024.120507","journal-title":"J Environ Manage"},{"issue":"5","key":"5802_CR11","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3322\/caac.21572","volume":"69","author":"M Carbone","year":"2019","unstructured":"Carbone M, Adusumilli PS, Alexander HR Jr et al (2019) Mesothelioma: scientific clues for prevention, diagnosis, and therapy. CA Cancer J Clin 69(5):402\u2013429. https:\/\/doi.org\/10.3322\/caac.21572","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"5802_CR12","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1001\/jamaoncol.2019.0446","volume":"5","author":"T Chen","year":"2019","unstructured":"Chen T, Sun XM, Wu L (2019) High time for complete ban on asbestos use in developing countries. JAMA Oncol 5(6):779\u2013780. https:\/\/doi.org\/10.1001\/jamaoncol.2019.0446","journal-title":"JAMA Oncol"},{"issue":"18","key":"5802_CR13","doi-asserted-by":"publisher","first-page":"6900","DOI":"10.3390\/ijerph17186900","volume":"17","author":"O Chimed-Ochir","year":"2020","unstructured":"Chimed-Ochir O, Arachi D, Driscoll T et al (2020) Burden of mesothelioma deaths by national income category: current status and future implications. Int J Environ Res Public Health 17(18):6900. https:\/\/doi.org\/10.3390\/ijerph17186900","journal-title":"Int J Environ Res Public Health"},{"key":"5802_CR14","volume-title":"Directive on the protection of workers from the risks related to exposure to asbestos at work","author":"Council of the European Union","year":"2023","unstructured":"Council of the European Union (2023) Directive on the protection of workers from the risks related to exposure to asbestos at work. Council of the European Union, Brussels"},{"issue":"10","key":"5802_CR15","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1038\/s41591-019-0583-3","volume":"25","author":"P Courtiol","year":"2019","unstructured":"Courtiol P, Maussion C, Moarii M et al (2019) Deep learning-based classification of mesothelioma improves prediction of patient outcome. Nat Med 25(10):1519\u20131525. https:\/\/doi.org\/10.1038\/s41591-019-0583-3","journal-title":"Nat Med"},{"issue":"Suppl 1","key":"5802_CR16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41379-021-00895-7","volume":"35","author":"S Dacic","year":"2022","unstructured":"Dacic S (2022) Pleural mesothelioma classification-update and challenges. Mod Pathol 35(Suppl 1):51\u201356. https:\/\/doi.org\/10.1038\/s41379-021-00895-7","journal-title":"Mod Pathol"},{"issue":"4","key":"5802_CR17","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.aogh.2014.09.016","volume":"80","author":"AL Frank","year":"2014","unstructured":"Frank AL, Joshi TK (2014) The global spread of asbestos. Ann Glob Health 80(4):257\u2013262. https:\/\/doi.org\/10.1016\/j.aogh.2014.09.016","journal-title":"Ann Glob Health"},{"issue":"11","key":"5802_CR18","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1136\/oemed-2016-103721","volume":"73","author":"P Franklin","year":"2016","unstructured":"Franklin P, Alfonso H, Reid A et al (2016) Asbestos exposure and histological subtype of malignant mesothelioma. Occup Environ Med 73(11):749\u2013752. https:\/\/doi.org\/10.1136\/oemed-2016-103721","journal-title":"Occup Environ Med"},{"key":"5802_CR19","doi-asserted-by":"publisher","first-page":"127588","DOI":"10.1016\/j.jhazmat.2021.127588","volume":"429","author":"GG Freemantle","year":"2022","unstructured":"Freemantle GG, Chetty D, Olifant M et al (2022) Assessment of asbestos contamination in soils at rehabilitated and abandoned mine sites, Limpopo Province. South Africa J Hazard Mater 429:127588. https:\/\/doi.org\/10.1016\/j.jhazmat.2021.127588","journal-title":"South Africa J Hazard Mater"},{"issue":"3","key":"5802_CR20","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1136\/oemed-2019-106008","volume":"77","author":"GBD 2016 Occupational Risk Factors Collaborators","year":"2020","unstructured":"GBD 2016 Occupational Risk Factors Collaborators (2020) Global and regional burden of disease and injury in 2016 arising from occupational exposures: a systematic analysis for the global burden of disease study 2016. Occup Environ Med 77(3):133\u2013141. https:\/\/doi.org\/10.1136\/oemed-2019-106008","journal-title":"Occup Environ Med"},{"issue":"10258","key":"5802_CR21","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"GBD 2019 Diseases and Injuries Collaborators","year":"2020","unstructured":"GBD 2019 Diseases and Injuries Collaborators (2020) Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. Lancet 396(10258):1204\u20131222. https:\/\/doi.org\/10.1016\/S0140-6736(20)30925-9","journal-title":"Lancet"},{"issue":"10","key":"5802_CR22","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1474-4422(21)00252-0","volume":"20","author":"GBD 2019 Stroke Collaborators","year":"2021","unstructured":"GBD 2019 Stroke Collaborators (2021) Global, regional, and national burden of stroke and its risk factors, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. Lancet Neurol 20(10):795\u2013820. https:\/\/doi.org\/10.1016\/S1474-4422(21)00252-0","journal-title":"Lancet Neurol"},{"key":"5802_CR23","doi-asserted-by":"publisher","first-page":"103821","DOI":"10.1016\/j.critrevonc.2022.103821","volume":"179","author":"Y Han","year":"2022","unstructured":"Han Y, Zhang T, Chen H et al (2022) Global magnitude and temporal trend of mesothelioma burden along with the contribution of occupational asbestos exposure in 204 countries and territories from 1990 to 2019: results from the global burden of disease study 2019. Crit Rev Oncol Hematol 179:103821. https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103821","journal-title":"Crit Rev Oncol Hematol"},{"issue":"7","key":"5802_CR24","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1513\/AnnalsATS.202209-802OC","volume":"20","author":"J Han","year":"2023","unstructured":"Han J, Park S, Yon DK et al (2023) Global, regional, and national burden of mesothelioma 1990\u20132019: a systematic analysis of the global burden of disease study 2019. Ann Am Thorac Soc 20(7):976\u2013983. https:\/\/doi.org\/10.1513\/AnnalsATS.202209-802OC","journal-title":"Ann Am Thorac Soc"},{"key":"5802_CR25","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1749-6632.1979.tb18712.x","volume":"330","author":"VL Henderson","year":"1979","unstructured":"Henderson VL, Enterline PE (1979) Asbestos exposure: factors associated with excess cancer and respiratory disease mortality. Ann N Y Acad Sci 330:117\u2013126. https:\/\/doi.org\/10.1111\/j.1749-6632.1979.tb18712.x","journal-title":"Ann N Y Acad Sci"},{"key":"5802_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.semcancer.2019.09.014","volume":"61","author":"TK Hinz","year":"2020","unstructured":"Hinz TK, Heasley LE (2020) Translating mesothelioma molecular genomics and dependencies into precision oncology-based therapies. Semin Cancer Biol 61:11\u201322. https:\/\/doi.org\/10.1016\/j.semcancer.2019.09.014","journal-title":"Semin Cancer Biol"},{"issue":"7","key":"5802_CR27","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1002\/cncr.33433","volume":"127","author":"ZI Hu","year":"2021","unstructured":"Hu ZI, Ghafoor A, Sengupta M et al (2021) Malignant mesothelioma: advances in immune checkpoint inhibitor and mesothelin-targeted therapies. Cancer 127(7):1010\u20131020. https:\/\/doi.org\/10.1002\/cncr.33433","journal-title":"Cancer"},{"issue":"6","key":"5802_CR28","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.jtho.2023.01.095","volume":"18","author":"J Huang","year":"2023","unstructured":"Huang J, Chan SC, Pang WS et al (2023) Global incidence, risk factors, and temporal trends of mesothelioma: a population-based study. J Thorac Oncol 18(6):792\u2013802. https:\/\/doi.org\/10.1016\/j.jtho.2023.01.095","journal-title":"J Thorac Oncol"},{"key":"5802_CR29","volume-title":"Asbestos: selected cancers","author":"Institute of Medicine Committee on Asbestos","year":"2006","unstructured":"Institute of Medicine Committee on Asbestos, Selected Health Effects (2006) Asbestos: selected cancers. National Academies Press (US), Washington"},{"key":"5802_CR56","unstructured":"International Agency for Research on Cancer. (2024). Agents classified by the IARC monographs. Available from: https:\/\/monographs.iarc.who.int\/list-of-classifications."},{"key":"5802_CR55","unstructured":"International Ban Asbestos Secretariat. (2022). Current Asbestos Bans. Available from: http:\/\/www.ibasecretariat.org\/alpha_ban_list.php. Accessed 28 Oct 2022"},{"issue":"13","key":"5802_CR30","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1056\/NEJMra1912719","volume":"385","author":"SM Janes","year":"2021","unstructured":"Janes SM, Alrifai D, Fennell DA (2021) Perspectives on the treatment of malignant pleural mesothelioma. N Engl J Med 385(13):1207\u20131218. https:\/\/doi.org\/10.1056\/NEJMra1912719","journal-title":"N Engl J Med"},{"issue":"8","key":"5802_CR31","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1177\/1403494815596500","volume":"43","author":"B Jarvholm","year":"2015","unstructured":"Jarvholm B, Burdorf A (2015) Emerging evidence that the ban on asbestos use is reducing the occurrence of pleural mesothelioma in Sweden. Scand J Public Health 43(8):875\u2013881. https:\/\/doi.org\/10.1177\/1403494815596500","journal-title":"Scand J Public Health"},{"issue":"2","key":"5802_CR32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.5271\/sjweh.4146","volume":"50","author":"B Jarvholm","year":"2024","unstructured":"Jarvholm B, Burdorf A (2024) Asbestos and disease - a public health success story? Scand J Work Environ Health 50(2):53\u201360. https:\/\/doi.org\/10.5271\/sjweh.4146","journal-title":"Scand J Work Environ Health"},{"key":"5802_CR33","doi-asserted-by":"publisher","first-page":"107511","DOI":"10.1016\/j.rmed.2023.107511","volume":"222","author":"AMH Khan","year":"2024","unstructured":"Khan AMH, Anwer SH, Sayed S et al (2024) Comprehensive clinical overview of malignant pleural mesothelioma. Respir Med 222:107511. https:\/\/doi.org\/10.1016\/j.rmed.2023.107511","journal-title":"Respir Med"},{"issue":"1","key":"5802_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.shaw.2023.11.002","volume":"15","author":"SY Kim","year":"2024","unstructured":"Kim SY, Chang HK, Kwon O et al (2024) Asbestos exposure and ovarian cancer: a meta-analysis. Saf Health Work 15(1):1\u20138. https:\/\/doi.org\/10.1016\/j.shaw.2023.11.002","journal-title":"Saf Health Work"},{"issue":"3","key":"5802_CR35","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1136\/oemed-2020-107222","volume":"79","author":"K Kwak","year":"2022","unstructured":"Kwak K, Kang D, Paek D (2022) Environmental exposure to asbestos and the risk of lung cancer: a systematic review and meta-analysis. Occup Environ Med 79(3):207\u2013214. https:\/\/doi.org\/10.1136\/oemed-2020-107222","journal-title":"Occup Environ Med"},{"key":"5802_CR36","doi-asserted-by":"publisher","first-page":"133874","DOI":"10.1016\/j.jhazmat.2024.133874","volume":"469","author":"T Lee","year":"2024","unstructured":"Lee T, Mischler SE, Wolfe C (2024) Classification of asbestos and their nonasbestiform analogues using FTIR and multivariate data analysis. J Hazard Mater 469:133874. https:\/\/doi.org\/10.1016\/j.jhazmat.2024.133874","journal-title":"J Hazard Mater"},{"issue":"3","key":"5802_CR37","doi-asserted-by":"publisher","first-page":"e25612","DOI":"10.1016\/j.heliyon.2024.e25612","volume":"10","author":"DEV Martinez","year":"2024","unstructured":"Martinez DEV, Saba M, Torres Gil LK (2024) Assessment of asbestos-cement roof distribution and prioritized intervention approaches through hyperspectral imaging. Heliyon 10(3):e25612. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e25612","journal-title":"Heliyon"},{"issue":"1","key":"5802_CR38","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1186\/s12889-024-18099-4","volume":"24","author":"X Miao","year":"2024","unstructured":"Miao X, Yao T, Dong C et al (2024) Global, regional, and national burden of non-communicable diseases attributable to occupational asbestos exposure 1990\u20132019 and prediction to 2035: worsening or improving? BMC Public Health 24(1):832. https:\/\/doi.org\/10.1186\/s12889-024-18099-4","journal-title":"BMC Public Health"},{"key":"5802_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.pulmoe.2024.02.002","author":"D Mukhopadhyay","year":"2024","unstructured":"Mukhopadhyay D, Cocco P, Orru S et al (2024) The role of MicroRNAs as early biomarkers of asbestos-related lung cancer: a systematic review and meta-analysis. Pulmonology. https:\/\/doi.org\/10.1016\/j.pulmoe.2024.02.002","journal-title":"Pulmonology"},{"issue":"10258","key":"5802_CR40","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","volume":"396","author":"GBD 2019 Risk Factors Collaborators","year":"2020","unstructured":"Murray CJ, Aravkin AY, Zheng P, Abbafati C, Abbas KM, Abbasi-Kangevari M, Borzouei S (2020) Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019. Lancet 396(10258):1223\u20131249. https:\/\/doi.org\/10.1016\/S0140-6736(20)30752-2","journal-title":"Lancet"},{"issue":"9","key":"5802_CR41","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.jtho.2018.06.011","volume":"13","author":"L Mutti","year":"2018","unstructured":"Mutti L, Peikert T, Robinson BWS et al (2018) Scientific advances and new frontiers in mesothelioma therapeutics. J Thorac Oncol 13(9):1269\u20131283. https:\/\/doi.org\/10.1016\/j.jtho.2018.06.011","journal-title":"J Thorac Oncol"},{"issue":"4","key":"5802_CR42","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/1878-0261.13591","volume":"18","author":"M Rigon","year":"2024","unstructured":"Rigon M, Mutti L, Campanella M (2024) Pleural mesothelioma (PMe): the evolving molecular knowledge of a rare and aggressive cancer. Mol Oncol 18(4):797\u2013814. https:\/\/doi.org\/10.1002\/1878-0261.13591","journal-title":"Mol Oncol"},{"issue":"9483","key":"5802_CR43","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","volume":"366","author":"BW Robinson","year":"2005","unstructured":"Robinson BW, Musk AW, Lake RA (2005) Malignant mesothelioma. Lancet 366(9483):397\u2013408. https:\/\/doi.org\/10.1016\/S0140-6736(05)67025-0","journal-title":"Lancet"},{"issue":"1","key":"5802_CR44","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/his.15065","volume":"84","author":"JJ Schulte","year":"2024","unstructured":"Schulte JJ, Husain AN (2024) Updates on grading mesothelioma. Histopathology 84(1):153\u2013162. https:\/\/doi.org\/10.1111\/his.15065","journal-title":"Histopathology"},{"issue":"5\u20136","key":"5802_CR45","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1080\/10937404.2016.1194254","volume":"19","author":"MJ Soeberg","year":"2016","unstructured":"Soeberg MJ, Leigh J, van Zandwijk N (2016) Malignant mesothelioma in Australia 2015: current incidence and asbestos exposure trends. J Toxicol Environ Health B Crit Rev 19(5\u20136):173\u2013189. https:\/\/doi.org\/10.1080\/10937404.2016.1194254","journal-title":"J Toxicol Environ Health B Crit Rev"},{"issue":"5","key":"5802_CR46","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/s1470-2045(09)70134-2","volume":"10","author":"K Straif","year":"2009","unstructured":"Straif K, Benbrahim-Tallaa L, Baan R et al (2009) A review of human carcinogens\u2013part C: metals, arsenic, dusts, and fibres. Lancet Oncol 10(5):453\u2013454. https:\/\/doi.org\/10.1016\/s1470-2045(09)70134-2","journal-title":"Lancet Oncol"},{"issue":"3","key":"5802_CR47","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"5802_CR48","first-page":"85","volume-title":"Worldwide asbestos supply and consumption trends from 1900 through 2003","author":"RL Virta","year":"2006","unstructured":"Virta RL (2006) Worldwide asbestos supply and consumption trends from 1900 through 2003. US Geological Survey, Reston, p 85"},{"issue":"1","key":"5802_CR49","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1186\/s12967-023-04761-9","volume":"21","author":"SD Visona","year":"2023","unstructured":"Visona SD, Bertoglio B, Favaron C et al (2023) A postmortem case control study of asbestos burden in lungs of malignant mesothelioma cases. J Transl Med 21(1):875. https:\/\/doi.org\/10.1186\/s12967-023-04761-9","journal-title":"J Transl Med"},{"key":"5802_CR50","doi-asserted-by":"publisher","DOI":"10.4081\/gh.2021.951","author":"E Wilk","year":"2021","unstructured":"Wilk E, Krowczynska M (2021) Malignant mesothelioma and asbestos exposure in Europe: evidence of spatial clustering. Geospat Health. https:\/\/doi.org\/10.4081\/gh.2021.951","journal-title":"Geospat Health"},{"key":"5802_CR51","volume-title":"Chrysotile asbestos","author":"World Health Organization","year":"2014","unstructured":"World Health Organization (2014) Chrysotile asbestos. World Health Organization, Geneva"},{"issue":"2","key":"5802_CR52","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41379-019-0332-7","volume":"33","author":"SK Wronkiewicz","year":"2020","unstructured":"Wronkiewicz SK, Roggli VL, Hinrichs BH et al (2020) Chrysotile fibers in tissue adjacent to laryngeal squamous cell carcinoma in cases with a history of occupational asbestos exposure. Mod Pathol 33(2):228\u2013234. https:\/\/doi.org\/10.1038\/s41379-019-0332-7","journal-title":"Mod Pathol"},{"issue":"1","key":"5802_CR53","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1038\/s41467-021-21798-w","volume":"12","author":"M Zhang","year":"2021","unstructured":"Zhang M, Luo JL, Sun Q et al (2021) Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironment. Nat Commun 12(1):1751. https:\/\/doi.org\/10.1038\/s41467-021-21798-w","journal-title":"Nat Commun"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-024-05802-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-024-05802-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-024-05802-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T23:27:04Z","timestamp":1717975624000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-024-05802-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,28]]},"references-count":56,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["5802"],"URL":"https:\/\/doi.org\/10.1007\/s00432-024-05802-6","relation":{},"ISSN":["1432-1335"],"issn-type":[{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,28]]},"assertion":[{"value":"23 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"This is an observational study. No ethical approval is required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"282"}}